ArticleClinical Medicine Insights. Oncology2026

Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review.

Matheus Sewastjanow-Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.